Vineet Laboratories Limited (NSE:VINEETLAB)
India · Delayed Price · Currency is INR 37.37
-0.13 (-0.35%)
Sep 4, 2026, 3:29 PM IST
Vineet Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 170.75 | 3.07 | 2.28 | 6.31 | 166.59 |
Cash & Short-Term Investments | 170.75 | 3.07 | 2.28 | 6.31 | 166.59 |
Cash Growth | 5465.42% | 34.68% | -63.88% | -96.21% | 692.66% |
Accounts Receivable | 113.99 | 132.47 | 316.04 | 351.63 | 361.98 |
Other Receivables | - | - | 0.59 | 0.3 | - |
Receivables | 113.99 | 132.47 | 316.63 | 351.93 | 361.98 |
Inventory | 640.91 | 499.71 | 493.94 | 461.74 | 435.4 |
Other Current Assets | 62.65 | 38.69 | 69.04 | 54.66 | 63.07 |
Total Current Assets | 988.29 | 673.94 | 881.88 | 874.63 | 1,027 |
Property, Plant & Equipment | 242.41 | 254.59 | 269.15 | 266.46 | 213.84 |
Long-Term Investments | 1.94 | 2.06 | 1.82 | 1.34 | 1.36 |
Long-Term Accounts Receivable | - | - | - | - | 40.34 |
Other Long-Term Assets | 15.2 | 14.81 | 15.87 | 16.07 | 50.58 |
Total Assets | 1,248 | 945.4 | 1,169 | 1,158 | 1,333 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 253.35 | 336.12 | 322.58 | 348.94 | 600.92 |
Accrued Expenses | 5.4 | 35.06 | 30.07 | 30.02 | 20.18 |
Short-Term Debt | - | 352.75 | 390.94 | 251.98 | 247.92 |
Current Portion of Long-Term Debt | 351.19 | 9.86 | 13.2 | 10.43 | - |
Current Income Taxes Payable | - | - | 1.22 | 4.4 | 28.69 |
Other Current Liabilities | 62.91 | 10.1 | 1.96 | 99.33 | 49.99 |
Total Current Liabilities | 672.85 | 743.89 | 759.96 | 745.1 | 947.69 |
Long-Term Debt | 102.07 | 37.86 | 38.86 | 48.48 | 17.22 |
Pension & Post-Retirement Benefits | - | 6.42 | 6.31 | 5.88 | 8.74 |
Long-Term Deferred Tax Liabilities | 12.51 | 9.13 | 14.59 | 20.54 | 17.91 |
Other Long-Term Liabilities | 4.39 | 1.62 | 1.76 | 1.67 | 9.42 |
Total Liabilities | 791.82 | 798.93 | 821.48 | 821.66 | 1,001 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 192.06 | 92.19 | 92.19 | 92.19 | 92.19 |
Retained Earnings | - | -59.24 | 142.67 | 132.4 | 129.1 |
Comprehensive Income & Other | 263.96 | 113.52 | 112.38 | 112.24 | 110.9 |
Shareholders' Equity | 456.02 | 146.48 | 347.24 | 336.84 | 332.18 |
Total Liabilities & Equity | 1,248 | 945.4 | 1,169 | 1,158 | 1,333 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 453.25 | 400.47 | 443 | 310.89 | 265.14 |
Net Cash (Debt) | -282.51 | -397.4 | -440.72 | -304.58 | -98.54 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -25.43 | -43.11 | -47.81 | -33.04 | -10.69 |
Filing Date Shares Outstanding | 16.86 | 9.22 | 9.22 | 9.22 | 9.22 |
Total Common Shares Outstanding | 16.86 | 9.22 | 9.22 | 9.22 | 9.22 |
Working Capital | 315.44 | -69.95 | 121.92 | 129.53 | 79.36 |
Book Value Per Share | 27.04 | 15.89 | 37.67 | 36.54 | 36.03 |
Tangible Book Value | 456.02 | 146.48 | 347.24 | 336.84 | 332.18 |
Tangible Book Value Per Share | 27.04 | 15.89 | 37.67 | 36.54 | 36.03 |
Land | - | 1.23 | 1.23 | 1.23 | 1.23 |
Buildings | - | 47.7 | 47.7 | 45.95 | - |
Machinery | - | 457.93 | 447.48 | 421.35 | 347.66 |